HLLY
Holley Inc.
HLLY has the edge over NIO overall, supported by stronger valuation and stronger modeled upside.
NIO
NIO Inc.
NIO offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
HLLY Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Weak |
HLLY's profitability and cash flow are currently healthy, and its revenue is stable, but its balance sheet is weak.
NIO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Stable | |
| Unavailable |
NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.
HLLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.6x | $1.05 | -55% |
| Current | 15x | $2.36 | — |
| Fair | 20x | $3.24 | +37% |
| Expensive | 28x | $4.43 | +88% |
Historical ranges are pointers, not guarantees.
HLLY's PE is in its fair range at 15x.
NIO PE Valuation
NIO has no meaningful PE right now: it lost money over the past year.
HLLY Forward outlook
There aren't enough analyst estimates for HLLY to show an outlook.
NIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect NIO's losses to shrink, with revenue growing.
HLLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.16 | +$0.38 |
| Q2 2026 | $0.09 | +$0.35 |
| Q1 2026 | $0.20 | +$0.41 |
| Q4 2025 | $0.16 | +$0.36 |
| Q3 2025 | -$0.22 | -283% |
| Q2 2025 | -$0.26 | -244% |
| Q1 2025 | -$0.21 | -240% |
| Q4 2024 | -$0.20 | -225% |
HLLY has the edge over NIO on earnings quality, reporting a profit while its opponent remains loss making.
NIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.29 | +$1.45 |
| Q1 2026 | -$0.60 | +$1.16 |
| Q4 2025 | -$1.06 | +$0.60 |
| Q3 2025 | -$1.59 | +$0.02 |
| Q2 2025 | -$1.74 | -$0.10 |
| Q1 2025 | -$1.76 | +$0.06 |
| Q4 2024 | -$1.66 | +$0.21 |
| Q3 2024 | -$1.61 | +$0.32 |
NIO is still losing money, but far less than before: $0.29 per share over the past year, against $1.93 at its worst in late 2023.
HLLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $141.6M | +2.3% |
| Q2 2026 | $172M | +3.2% |
| Q1 2026 | $147.3M | -3.7% |
| Q4 2025 | $155.4M | +11% |
| Q3 2025 | $138.4M | +3.2% |
| Q2 2025 | $166.7M | -1.7% |
| Q1 2025 | $153M | -3.5% |
| Q4 2024 | $140.1M | -10% |
HLLY's revenue fell from its 2022 peak and has held roughly level since: $142M last quarter, up 2.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +2.3 points |
| Q2 2026 | 1.6% | -15 points |
| Q1 2026 | 12% | -0.8 points |
| Q4 2025 | 13% | +33 points |
| Q3 2025 | 11% | +7.3 points |
| Q2 2025 | 17% | +0.1 points |
| Q1 2025 | 13% | +6.2 points |
| Q4 2024 | -21% | -33 points |
HLLY has the edge over NIO on profitability, with a higher operating margin.
NIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +69% |
| Q1 2026 | $3.8B | +112% |
| Q4 2025 | $5.2B | +76% |
| Q3 2025 | $3.3B | +17% |
| Q2 2025 | $2.9B | +9% |
| Q1 2025 | $1.8B | +21% |
| Q4 2024 | $3B | +15% |
| Q3 2024 | $2.8B | -2.1% |
NIO has the edge over HLLY on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.1% | +24 points |
| Q1 2026 | -1.2% | +52 points |
| Q4 2025 | 2.3% | +33 points |
| Q3 2025 | -16% | +12 points |
| Q2 2025 | -26% | +4 points |
| Q1 2025 | -53% | +1.1 points |
| Q4 2024 | -31% | +8.1 points |
| Q3 2024 | -28% | -2.6 points |
NIO's operating margin was −2.1% last quarter, up 24 points from the same quarter a year ago.
HLLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.8M | +66% |
| Q2 2026 | $40.9M | +15% |
| Q1 2026 | -$6.3M | +$4.5M |
| Q4 2025 | $3.8M | +123% |
| Q3 2025 | $5.3M | +$8.8M |
| Q2 2025 | $35.7M | +47% |
| Q1 2025 | -$10.8M | -162% |
| Q4 2024 | $1.7M | -94% |
HLLY has the edge over NIO on cash flow, with more consistent year-over-year improvement.
NIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$2.1B |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$391.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$2.1B | +$73.9M |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$391.3M | -386% |
| Q2 2024 | -$2.2B | +$337.9M |
NIO's free cash flow was $0 over the past year, against −$2.5B the year before.
HLLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +593K shares |
| 1 year | +1.2% | +1.5M shares |
| 3 years | +1.4% | +1.6M shares |
| 5 years | +1170% | +111M shares |
HLLY has the edge over NIO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
NIO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +15.6M shares |
| 1 year | +12% | +267M shares |
| 3 years | +51% | +844M shares |
| 5 years | +60% | +933M shares |
| Available history | +143% | +1.5B shares |
NIO has 2.5B diluted shares, up 12% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
NIO hasn't bought back shares in the past year.
HLLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.4x | High |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 4.8x | High |
| Q4 2025 | 4.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 10.3x | High |
| Q1 2025 | 10.6x | High |
| Q4 2024 | 12.7x | High |
HLLY's net debt is about 5.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago.
NIO Net Leverage
NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HLLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.6 | Neutral |
| Stochastic | 21.7 | Neutral |
HLLY's weekly RSI is 43 (neutral) and its Stochastic is 22 (neutral).
NIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 6.9 | Oversold |
NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
HLLY PE vs Consumer Cyclical Sector
| Metric | HLLY | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 18x | 18% below |
| PE % | 34 | 49 | 15 pts below |
HLLY is trading at 15x earnings, a 18% discount to the Consumer Cyclical sector's median of 18x.
NIO PE vs Consumer Cyclical Sector
NIO has no meaningful PE right now: it lost money over the past year.
HLLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.42 | 2.5% below |
| 20 week MA | $2.64 | 11% below |
| 50 week MA | $3.11 | 24% below |
| 100 week MA | $2.94 | 20% below |
| 200 week MA | $3.39 | 30% below |
HLLY is in a downtrend: it's below all five of its weekly moving averages, and 30% below its 200-week average.
NIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 9.2% below |
| 20 week MA | $4.01 | 24% below |
| 50 week MA | $4.81 | 37% below |
| 100 week MA | $4.85 | 37% below |
| 200 week MA | $6.03 | 49% below |
NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.
HLLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.75 | $10.0 | +2.7% |
| 2021 | $10.0 | $12.6 | +26% |
| 2022 | $12.6 | $2.04 | -84% |
| 2023 | $2.04 | $4.87 | +139% |
| 2024 | $4.87 | $3.00 | -38% |
| 2025 | $3.00 | $4.17 | +39% |
| 2026 YTD | $4.17 | $2.36 | -43% |
HLLY's yearly returns have swung widely, from +139% in 2023 to −84% in 2022. It's down 43% so far in 2026.
NIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.42 | $45.8 | +1791% |
| 2021 | $45.8 | $30.5 | -33% |
| 2022 | $30.5 | $11.0 | -64% |
| 2023 | $11.0 | $9.07 | -17% |
| 2024 | $9.07 | $4.48 | -51% |
| 2025 | $4.48 | $5.10 | +14% |
| 2026 YTD | $5.10 | $3.05 | -40% |
NIO has the edge over HLLY on returns for 2026, with the stronger performance.